Rudnik-Schöneborn Sabine, Botzenhart Elke, Eggermann Thomas, Senderek Jan, Schoser Benedikt G H, Schröder Rolf, Wehnert Manfred, Wirth Brunhilde, Zerres Klaus
Institute for Human Genetics, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.
Neurogenetics. 2007 Apr;8(2):137-42. doi: 10.1007/s10048-006-0070-0. Epub 2006 Nov 29.
The molecular basis of autosomal dominant spinal muscular atrophy (AD-SMA) is largely unknown. Because the phenotypic spectrum of diseases caused by LMNA mutations is extremely broad and includes myopathies, neuropathies, and cardiomyopathies designated as class 1 laminopathies, we sequenced the LMNA gene in index patients with the clinical picture of proximal SMA, who had a family history suggestive of autosomal dominant inheritance. Among the 19 families investigated, two showed pathogenic mutations of the LMNA gene, resulting in the diagnosis of a class 1 laminopathy in about 10% of our series. We found one novel truncating mutation (c.1477C > T, Q493X) and one previously described missense mutation (c.1130G > T, R377H) in the LMNA gene of two unrelated patients with adult-onset proximal SMA followed by cardiac involvement 14 and 22 years after the onset of weakness. The pedigrees of both families revealed a high frequency of cardiac abnormalities or sudden deaths. Our findings extend the spectrum of laminopathies and are of relevance for genetic counseling and clinical care of families presenting with adult-onset proximal SMA. Particularly, if neurogenic atrophy is combined with a cardiac disease in a family, this should prompt LMNA mutation analysis.
常染色体显性遗传性脊髓性肌萎缩症(AD-SMA)的分子基础在很大程度上尚不清楚。由于由LMNA基因突变引起的疾病表型谱极为广泛,包括被指定为1型核纤层蛋白病的肌病、神经病和心肌病,我们对具有近端SMA临床表现且有常染色体显性遗传家族史的先证者进行了LMNA基因测序。在研究的19个家族中,有两个家族显示出LMNA基因的致病突变,在我们的研究系列中约10%的患者被诊断为1型核纤层蛋白病。我们在两名成年起病的近端SMA且在肌无力发作后14年和22年出现心脏受累的无关患者的LMNA基因中发现了一个新的截短突变(c.1477C>T,Q493X)和一个先前描述的错义突变(c.1130G>T,R377H)。两个家族的系谱显示心脏异常或猝死的发生率很高。我们的发现扩展了核纤层蛋白病的谱,对于成年起病的近端SMA家庭的遗传咨询和临床护理具有重要意义。特别是,如果一个家族中神经源性萎缩与心脏病合并出现,这应促使进行LMNA突变分析。